Cellid, Co., Ltd. (KOSDAQ:299660)
South Korea · Delayed Price · Currency is KRW 2,780.00
-70.00 (-2.46%)
At close: Feb 27, 2026
Cellid, Market Cap
Cellid, has a market cap or net worth of 82.02 billion as of February 27, 2026. Its market cap has decreased by -19.45% in one year.
Market Cap
82.02B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2,780.00
Market Cap Chart
Since February 20, 2019, Cellid,'s market cap has decreased from 482.44B to 82.02B, a decrease of -83.00%. That is a compound annual growth rate of -22.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 82.02B | -2.80% |
| Dec 30, 2025 | 84.38B | -20.98% |
| Dec 30, 2024 | 106.78B | 75.61% |
| Dec 28, 2023 | 60.81B | -46.82% |
| Dec 29, 2022 | 114.34B | -76.07% |
| Dec 30, 2021 | 477.80B | 21.04% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 20, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.31T |
| Celltrion | 52.20T |
| ALTEOGEN | 21.79T |
| Sam Chun Dang Pharm. | 19.19T |
| Humasis | 89.73B |
| Ray Co., Ltd. | 88.93B |
| BIT Computer | 88.88B |
| Enzychem Lifesciences | 87.65B |